The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Marshall, N. A.
Right arrow Articles by Barker, R. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Marshall, N. A.
Right arrow Articles by Barker, R. N.
The Journal of Immunology, 2003, 170: 6183-6189.
Copyright © 2003 by The American Association of Immunologists

Regulatory T Cells Secreting IL-10 Dominate the Immune Response to EBV Latent Membrane Protein 11

Neil A. Marshall, Mark A. Vickers and Robert N. Barker2

Department of Medicine and Therapeutics, University of Aberdeen, Foresterhill, Aberdeen, United Kingdom

Viruses exploit a number of strategies to evade immune recognition. In this study, we describe a novel mechanism by which EBV, rather than avoiding detection, subverts the immune response by stimulating regulatory T cells that secrete IL-10. Human PBMC from all EBV-seropositive, but not -seronegative, donors responded to both purified latent membrane protein 1 and the corresponding immunodominant peptides with high levels of IL-10 secretion by CD4+ T cells. These IL-10 responses, characteristic of T regulatory 1 cells, inhibited T cell proliferation and IFN-{gamma} secretion induced by both mitogen and recall Ag. It was confirmed that the inhibition was IL-10 dependent by the use of neutralizing Ab. The deviation of the immune response toward suppression is likely to be important in maintaining latency and EBV-associated tumors.




This article has been cited by other articles:


Home page
J. Immunol.Home page
P. P. Sarangi, S. Sehrawat, S. Suvas, and B. T. Rouse
IL-10 and Natural Regulatory T Cells: Two Independent Anti-Inflammatory Mechanisms in Herpes Simplex Virus-Induced Ocular Immunopathology
J. Immunol., May 1, 2008; 180(9): 6297 - 6306.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
H. Kobayashi, T. Nagato, M. Takahara, K. Sato, S. Kimura, N. Aoki, M. Azumi, M. Tateno, Y. Harabuchi, and E. Celis
Induction of EBV-Latent Membrane Protein 1-Specific MHC Class II-Restricted T-Cell Responses against Natural Killer Lymphoma Cells
Cancer Res., February 1, 2008; 68(3): 901 - 908.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
F. J. Ward, A. M. Hall, L. S. Cairns, A. S. Leggat, S. J. Urbaniak, M. A. Vickers, and R. N. Barker
Clonal regulatory T cells specific for a red blood cell autoantigen in human autoimmune hemolytic anemia
Blood, January 15, 2008; 111(2): 680 - 687.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
S. Li, E. J. Gowans, C. Chougnet, M. Plebanski, and U. Dittmer
Natural Regulatory T Cells and Persistent Viral Infection
J. Virol., January 1, 2008; 82(1): 21 - 30.
[Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
W. J. Pickford, A. J.M. Watson, and R. N. Barker
Different Forms of Helper Tolerance to Carcinoembryonic Antigen: Ignorance and Regulation
Clin. Cancer Res., August 1, 2007; 13(15): 4528 - 4537.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. K. Gandhi, E. Lambley, J. Duraiswamy, U. Dua, C. Smith, S. Elliott, D. Gill, P. Marlton, J. Seymour, and R. Khanna
Expression of LAG-3 by tumor-infiltrating lymphocytes is coincident with the suppression of latent membrane antigen-specific CD8+ T-cell function in Hodgkin lymphoma patients
Blood, October 1, 2006; 108(7): 2280 - 2289.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. J. Robertson, R. J. Messer, A. B. Carmody, and K. J. Hasenkrug
In Vitro Suppression of CD8+ T Cell Function by Friend Virus-Induced Regulatory T Cells
J. Immunol., March 15, 2006; 176(6): 3342 - 3349.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
T. Alvaro, M. Lejeune, M. T. Salvado, R. Bosch, J. F. Garcia, J. Jaen, A. H. Banham, G. Roncador, C. Montalban, and M. A. Piris
Outcome in Hodgkin's Lymphoma Can Be Predicted from the Presence of Accompanying Cytotoxic and Regulatory T Cells
Clin. Cancer Res., February 15, 2005; 11(4): 1467 - 1473.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
N. A. Marshall, L. E. Christie, L. R. Munro, D. J. Culligan, P. W. Johnston, R. N. Barker, and M. A. Vickers
Immunosuppressive regulatory T cells are abundant in the reactive lymphocytes of Hodgkin lymphoma
Blood, March 1, 2004; 103(5): 1755 - 1762.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
R. H. Edwards, D. Sitki-Green, D. T. Moore, and N. Raab-Traub
Potential Selection of LMP1 Variants in Nasopharyngeal Carcinoma
J. Virol., January 15, 2004; 78(2): 868 - 881.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2003 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2003 by The American Association of Immunologists, Inc. All rights reserved.